Total Payments
$1.4M
2024 Payments
$214,944
Companies
44
Transactions
2,076
Medicare Patients
3,201
Medicare Billing
$625,694
Payment Breakdown by Category
Other$1.3M (87.7%)
Travel$90,121 (6.3%)
Food & Beverage$44,555 (3.1%)
Consulting$42,842 (3.0%)
Education$410.16 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.3M | 542 | 87.6% |
| Travel and Lodging | $90,121 | 425 | 6.3% |
| Food and Beverage | $44,555 | 1,073 | 3.1% |
| Consulting Fee | $42,842 | 27 | 3.0% |
| Education | $410.16 | 8 | 0.0% |
| Honoraria | $225.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $974,262 | 1,023 | $0 (2024) |
| Grifols USA, LLC | $185,955 | 217 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $88,991 | 135 | $0 (2024) |
| Mylan Specialty L.P. | $74,097 | 115 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $38,951 | 81 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $30,678 | 49 | $0 (2024) |
| Amgen Inc. | $21,226 | 24 | $0 (2024) |
| Genentech USA, Inc. | $10,852 | 28 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $7,327 | 40 | $0 (2023) |
| Grifols Shared Services North America, Inc. | $2,460 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $214,944 | 221 | AstraZeneca Pharmaceuticals LP ($144,887) |
| 2023 | $216,478 | 288 | AstraZeneca Pharmaceuticals LP ($143,462) |
| 2022 | $159,581 | 250 | AstraZeneca Pharmaceuticals LP ($117,416) |
| 2021 | $166,117 | 247 | AstraZeneca Pharmaceuticals LP ($140,375) |
| 2020 | $113,041 | 183 | AstraZeneca Pharmaceuticals LP ($77,647) |
| 2019 | $234,255 | 328 | AstraZeneca Pharmaceuticals LP ($165,669) |
| 2018 | $223,214 | 367 | AstraZeneca Pharmaceuticals LP ($141,251) |
| 2017 | $113,279 | 192 | Grifols USA, LLC ($48,845) |
All Payment Transactions
2,076 individual payment records from CMS Open Payments — Page 1 of 84
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $110.59 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,511.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | Cash or cash equivalent | $104.46 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Pulmonology | ||||||
| 11/15/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,920.00 | General |
| Category: Pulmonology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,920.00 | General |
| Category: Pulmonology | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Pulmonology | ||||||
| 11/07/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,511.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | Cash or cash equivalent | $123.33 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 635 | 1,391 | $297,400 | $155,816 |
| 2022 | 12 | 781 | 1,562 | $358,800 | $173,417 |
| 2021 | 15 | 822 | 1,528 | $324,840 | $156,384 |
| 2020 | 19 | 963 | 1,514 | $281,005 | $140,077 |
Total Patients
3,201
Total Services
5,995
Medicare Billing
$625,694
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 99 | 383 | $124,130 | $62,113 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 384 | $48,000 | $34,796 | 72.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 314 | $40,820 | $28,324 | 69.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 107 | $23,540 | $14,081 | 59.8% |
| 32557 | Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | Facility | 2023 | 18 | 54 | $43,200 | $5,983 | 13.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 67 | $6,700 | $4,000 | 59.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $4,860 | $3,049 | 62.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 34 | 40 | $4,800 | $2,461 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 15 | $1,350 | $1,009 | 74.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 125 | 444 | $137,640 | $73,710 | 53.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 124 | 374 | $48,620 | $28,852 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 294 | $36,750 | $25,698 | 69.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 120 | 141 | $31,020 | $21,154 | 68.2% |
| 32557 | Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | Facility | 2022 | 34 | 90 | $72,000 | $10,133 | 14.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $5,760 | $3,644 | 63.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 61 | $6,100 | $3,230 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 38 | $3,420 | $2,308 | 67.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 34 | 37 | $4,440 | $2,021 | 45.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 11 | 16 | $2,400 | $1,335 | 55.6% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 16 | 18 | $8,100 | $1,152 | 14.2% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 15 | 17 | $2,550 | $180.28 | 7.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 105 | 366 | $113,460 | $60,707 | 53.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 200 | 316 | $39,500 | $28,419 | 71.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 110 | 324 | $42,120 | $25,353 | 60.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 98 | 109 | $23,980 | $16,522 | 68.9% |
About Dr. David Mares, MD
Dr. David Mares, MD is a Critical Care Medicine healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396770335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Mares, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $214,944 received in 2024. These payments were reported across 2,076 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.3M).
As a Medicare-enrolled provider, Mares has provided services to 3,201 Medicare beneficiaries, totaling 5,995 services with total Medicare billing of $625,694. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Anderson, IN
- Active Since 07/11/2006
- Last Updated 12/19/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1396770335
Products in Payments
- FASENRA (Drug) $336,056
- BREZTRI (Drug) $220,145
- FASENRA (Biological) $153,735
- TEZSPIRE (Biological) $148,592
- Prolastin-C (Biological) $92,330
- Prolastin-C Liquid (Biological) $85,499
- BEVESPI AEROSPHERE (Drug) $50,476
- Yupelri (Drug) $49,653
- AIRSUPRA (Drug) $32,991
- BREZTRI AEROSPHERE (Drug) $26,880
- LONHALA MAGNAIR (Drug) $25,483
- YUPELRI (Drug) $24,425
- DUPIXENT (Biological) $19,283
- UTIBRON (Drug) $12,088
- SYMBICORT (Drug) $10,783
- Xembify (Biological) $10,586
- XARELTO (Drug) $7,327
- Xolair (Biological) $1,787
- Utibron (Drug) $1,349
- SPIRIVA (Drug) $1,110
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Anderson
Pablo Molina, Md, MD
Critical Care Medicine — Payments: $14,829
Critical Care Medicine $14,829
Stephen Hand, Md, MD
Critical Care Medicine — Payments: $7,712
Critical Care Medicine $7,712
Moayyed Moallem, Md, MD
Critical Care Medicine — Payments: $4,275
Critical Care Medicine $4,275
Anas Alsadi, Md, MD
Critical Care Medicine — Payments: $4,137
Critical Care Medicine $4,137
Thomas Bright, Md, MD
Critical Care Medicine — Payments: $3,291
Critical Care Medicine $3,291
Christine Del Prado-Rico, Md, MD
Critical Care Medicine — Payments: $150.25
Critical Care Medicine $150.25